Latest Non-steroidal anti-inflammatory drugs Stories
After many years of gradual increase followed by a three-year levelling off period, sales of addictive anxiolytic and hypnotic drugs decreased by just under two per cent in 2010.
The reduced risk of colorectal cancer associated with taking aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may be confined to individuals already at risk because of elevations in a particular inflammatory factor in the blood.
Researchers found that ibuprofen may offer protection against developing Parkinson's disease.
The over-the-counter drug, ibuprofen, may offer protection against developing Parkinsonâ€™s disease.
Men who use non-steroidal anti-inflammatory drugs (NSAIDs) three times a day for more than three months are 38 percent more likely to have erectile dysfunction (ED) as men who do not regularly take these drugs.
According to a new report from the American Academy of Pediatrics (AAP), researchers say parents should not immediately rush for medicines when their child displays signs of fever, as fever alone is not a cause for intervention.
New research shows that medications which have raised safety concerns over heart attack and stroke risks may not have gotten approval from the Food and Drug Administration (FDA) if the cardiovascular effects of fluid retention had been better understood.
NASHVILLE, Tenn., Feb. 15, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced the publication of data from a clinical trial evaluating the pharmacokinetics, safety and tolerability of a rapid infusion of CaldolorÂ® (ibuprofen) Injection compared to oral ibuprofen.
DENVER, Feb. 7, 2011 /PRNewswire/ -- Colorado start-up, UrgentRx, today announced the launch of a new line of fast-acting, powdered medications in convenient credit card-sized packets, including UrgentRx Aspirin to Go, a life-saving product specifically developed as heart attack first aid.
NASHVILLE, Tenn., Jan. 27, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced the publication of data affirming the safety and efficacy of CaldolorÂ® (ibuprofen) Injection in treating post-operative pain in hospitalized patients.
- A political dynamiter.
More Images (1 images) »